Thursday, September 29, 2016 |Latest E-book
You are here:
Novartis
#

Novartis

Articles

Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brands

Sep 06, 2016

Sun Pharma inks distribution alliance with Mitsubishi Tanabe for 14 brands

These 14 prescription brands acquired by the company earlier this year will be transferred from Novartis Pharma K.K. to Sun Pharma's subsidiary in Japan beginning October 2016 #Sun Pharma #Novartis #drug firm #Mitsubishi Tanabe Pharma Corporation #14 brands
Prices of cancer, diabetes, blood pressure drugs slashed by 25%

Jun 06, 2016

Prices of cancer, diabetes, blood pressure drugs slashed by 25%

Prices of 56 important drugs used in treatment of cancer, diabetes, bacterial infections and blood pressure have been capped by the government thereby reducing the cost by an average of around 25 percent. #NewsTracker #Cipla #Lupin #Healthcare #Biocon #Novartis #Intas Pharmaceuticals #National Pharmaceutical Pricing Authority #Alkem Laboratories #Alembic #Hetero Healthcare #reduced drugs prices #reduced medicine prices
Prices of 56 drugs to come down; NPPA fixes ceiling rates

Jun 06, 2016

Prices of 56 drugs to come down; NPPA fixes ceiling rates

Prices may come down of 56 important medicines used in treatment of cancer, diabetes, bacterial infections and high blood pressure, with the government fixing their ceiling prices under the drug pricing control mechanism. #Cipla #Lupin #Biocon #Medicines #cancer treatment #Novartis #Drug prices #NPPA #DPCO #Alkem Laboratories #Abbott Healthcare #Alembic
PM invites Swiss business leaders to invest in India

Jun 06, 2016

PM invites Swiss business leaders to invest in India

Seeking to create two or three Switzerlands within India, Prime Minister Narendra Modi today courted Swiss business leaders to boost domestic manufacturing and skill development. #Nestle #ABB #Geneva #Lafarge #Novartis #PM Narendra Modi #Switzerland visit #Swiss business leaders
Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%

Dec 31, 2015

Warning letters for pharma cos galore: Now Cadila Healthcare faces USFDA heat, stock tanks 16%

The Ahmedabad-headquartered company received a warning letter for its Moraiya formulation facility and Ahmedabad API facility #Sun Pharmaceuticals #Cadila Healthcare #US FDA #Novartis #Dr Reddy's Lab #Halol plant
India needs predictable IPR regime, says Novartis

Nov 17, 2015

India needs predictable IPR regime, says Novartis

If the whole data regulatory process becomes predictable in the long run, it makes investment in the country more sustainable, said Novartis Pharma AG, Global Head of Development, Established Medicines Franchise, Lutz Hegemann. #Health #CompanyWatch #World Trade Organization #Novartis #Pharma industry #IPR regime #Compulsory License #Lutz Hegemann
Natco Pharma gains 4.5% after filing ANDA with USFDA

Feb 10, 2015

Natco Pharma gains 4.5% after filing ANDA with USFDA

Natco Pharma has filed new product applications with the US health regulator for generic version of drugs used in the treatment of nervous system disease and cancer. #India #US #Generic drug #generic drug makers #Sanofi #Natco Pharma #Novartis #Jevtana #ANDA #Cabazitaxel #Fingolimod #Gilenya
Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Jan 14, 2015

Delhi HC bars Cipla from selling cheaper copy of Novartis respiratory drug

Cipla, India's fourth-largest generic drugmaker by revenue, had launched its copy of Onbrez in New Delhi in October last year at a fifth of the original drug's price, citing urgent unmet need in India. #India #NewsTracker #Delhi High Court #Cipla #Novartis #respiratory drug #Onbrez
Novartis sues Cipla for infringing respiratory drug patent

Dec 17, 2014

Novartis sues Cipla for infringing respiratory drug patent

Swiss drugmaker Novartis AG said on Wednesday it had sued India's Cipla Ltd for infringing patents covering its respiratory drug Onbrez, a month after Cipla launched a copy at a fifth of the original drug's price. #Cipla #Lupin #Patent #Pharma #US FDA #Novartis #sue #USTR #generic #Onbrez
Did Tata Memorial Hospital intentionally loot its cancer patients?

Nov 23, 2014

Did Tata Memorial Hospital intentionally loot its cancer patients?

Tata Memorial Hospital in Mumbai has admitted to overcharging cancer patients for a Novartis-branded oncology medicine over the last nine months, #Novartis #Tata Memorial Hospital #cancer patients #oncology medicine